Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer

被引:59
|
作者
Porta, M
Malats, N
Guarner, L
Carrato, A
Rifà, J
Salas, A
Corominas, JM
Andreu, M
Real, FX
机构
[1] Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain
[2] Hosp Gen Valle Hebron, Dept Gastroenterol, Barcelona, Spain
[3] Hosp Gen Elche, Dept Oncol, Alicante, Spain
[4] Hosp Son Dureta, Dept Oncol, Mallorca, Spain
[5] Hosp Mutua Terrassa, Dept Pathol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08003 Barcelona, Spain
[7] Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, E-08003 Barcelona, Spain
关键词
D O I
10.1136/jech.53.11.702
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. Design-Case-case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. Setting and patients-All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n=185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. Main results-Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among nonregular coffee drinkers (82.0% v 55.6%, p=0.018, n=107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p<0.05). With respect to non-regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of greater than or equal to 15 cups/week (p<0.01, test for trend). Conclusions-Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.
引用
收藏
页码:702 / 709
页数:8
相关论文
共 50 条
  • [21] Validation of Blood Testing for K-ras Mutations in Colorectal and Pancreatic Cancer
    Rogosnitzky, Moshe
    Danks, Rachel
    ANTICANCER RESEARCH, 2010, 30 (07) : 2943 - 2947
  • [22] Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients
    Takanori Uemura
    Kenji Hibi
    Tetsuya Kaneko
    Shin Takeda
    Soichiro Inoue
    Osamu Okochi
    Tetsuro Nagasaka
    Akimasa Nakao
    Journal of Gastroenterology, 2004, 39 : 56 - 60
  • [23] Occupational exposure to hydrocarbon solvents and K-ras activation in exocrine pancreatic cancer.
    Alguacil, J
    Porta, M
    Malats, N
    Kogevinas, M
    Kauppinen, T
    Partanen, T
    Benavides, FG
    Real, FX
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S265 - S265
  • [24] The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations
    Fryzek J.P.
    Garabrant D.H.
    Schenk M.
    Kinnard M.
    Greenson J.K.
    Sarkar F.H.
    Journal of Gastrointestinal Cancer, 2006, 37 (4): : 139 - 145
  • [25] The Role of K-ras Mutations in Pancreatic Neuroendocrine Tumors
    Gilliland, K.
    Dong, H. J.
    Hochwald, S.
    Liu, C.
    MODERN PATHOLOGY, 2010, 23 : 355A - 356A
  • [26] Identification of K-ras mutations in pancreatic juice - Reply
    Berthelemy, P
    Bouisson, M
    Pradayrol, L
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) : 1014 - 1015
  • [27] The Role of K-ras Mutations in Pancreatic Neuroendocrine Tumors
    Gilliland, K.
    Dong, H. J.
    Hochwald, S.
    Liu, C.
    LABORATORY INVESTIGATION, 2010, 90 : 355A - 356A
  • [28] K-RAS MUTATIONS IN PANCREATIC DUCTAL PROLIFERATIVE LESIONS
    KLIMSTRA, DS
    LONGNECKER, DS
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (06): : 1547 - 1548
  • [29] K-ras protooncogene mutations in feline pancreatic adenocarcinomas
    Mayr, B
    Schaffner, G
    Reifinger, M
    Loupal, G
    VETERINARY RECORD, 2003, 153 (15) : 468 - +
  • [30] Prevalence of K-ras mutations at diagnosis and serum levels of DDT, DDE, PCBs and other organochlorine compounds in exocrine pancreatic cancer
    Porta, M
    Jariod, M
    Malats, N
    Grimalt, JO
    Carrato, A
    Guarner, L
    Salas, A
    Rifà, J
    Corominas, JM
    Alguacil, J
    Andreu, M
    Real, FX
    MOLECULAR PATHOGENESIS OF PANCREATIC CANCER, 2000, 41 : 37 - 44